The invention relates to furo[3,2-b]pyridines substituted at least in position 5 as inhibitors of protein kinases, regulators or modulators, methods of preparation thereof, pharmaceutical compositions containing the compounds, and pharmaceutical use of the compounds and compositions in the treatment of the diseases such as, for example, cancer or neurodegenerative diseases. (Formula (I))
该发明涉及在位置5上至少取代的
噻吩并[3,2-b]
吡啶作为蛋白激酶的
抑制剂,调节剂或调节剂,其制备方法,含有这些化合物的药物组合物,以及这些化合物和组合物在治疗癌症或神经退行性疾病等疾病中的药用。 (式(I))